Volume 178, Issue 1 pp. 13-18

Reconstitution of active recombinant Shiga toxin (Stx)1 from recombinant Stx1-A and Stx1-B subunits independently produced by E. coli clones

Toru Nishikawa

Toru Nishikawa

Shionogi Research Laboratories, Shionogi and Co. Ltd., Futaba-cho, Toyonaka-shi, Osaka 561-0825, Japan

Search for more papers by this author
Jun Fujii

Jun Fujii

Department of Microbiology, School of Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu 807-8555, Japan

Search for more papers by this author
Shin-ichi Yoshida

Shin-ichi Yoshida

Department of Bacteriology, Faculty of Medicine, Kyushu University, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

Search for more papers by this author
Takashi Yutsudo

Corresponding Author

Takashi Yutsudo

Shionogi Research Laboratories, Shionogi and Co. Ltd., Futaba-cho, Toyonaka-shi, Osaka 561-0825, Japan

*Corresponding author. Tel.: +81 (6) 6331-8081; Fax: +81 (6) 6331-8612, E-mail address: [email protected]Search for more papers by this author
First published: 17 January 2006
Citations: 1

Abstract

Escherichia coli clones expressing recombinant Shiga toxin (Stx)1-A and recombinant Stx1-B subunits, were established. Culture supernatants of these clones were examined for inhibitory activity on in vitro protein synthesis using luciferase as a reporter enzyme. Culture supernatant of the clone expressing Stx1-A, but not Stx1-B, showed the inhibitory activity. Neither recombinant Stx1-A nor Stx1-B showed Vero cell cytotoxicity. For reconstitution of biologically active toxin, the culture supernatants of the Stx1-A clone and the Stx1-B clone were mixed. The reconstituted recombinant Stx1 showed both Vero cell cytotoxicity and inhibition of in vitro protein synthesis.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.